axi-cel

Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Fierce Pharma
Thu, 10/19/17 - 09:12 am
Gilead Sciences
Kite Pharma
Novartis
CAR-T
FDA
axi-cel
Yescarta
non-Hodgkin's lymphoma
large B-cell lymphoma
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition
Motley Fool
Mon, 09/11/17 - 09:17 pm
Gilead Sciences
Kite Pharma
M&A
axi-cel
pay-for-performance
Gilead agrees to buy Kite Pharma, leaping into CAR-T cancer therapy
Stat
Mon, 08/28/17 - 10:04 am
Gilead Sciences
Kite Pharma
CAR-T
M&A
axi-cel
Prepping for a rapid-fire launch, Kite Pharma gets a pass from FDA on axi-cel panel review
Endpoints
Tue, 08/8/17 - 11:26 am
Kite Pharma
FDA
drug launches
axi-cel
Novartis' CAR-T stacks up to Kite in lymphoma
BioPharma Dive
Wed, 06/7/17 - 07:04 pm
Novartis
CAR-T
Kite Pharma
CTL019
axi-cel
lymphoma